Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 397 | 261 | 280 | 645 | 466 |
| Receivables | 71 | 6 | 6 | 4 | 1 |
| TOTAL | $1,141 | $1,350 | $1,747 | $2,453 | $1,187 |
| Non-Current Assets | |||||
| Intangibles | 640 | 673 | 705 | 738 | 771 |
| Other Non-Current Assets | 10,429 | 10,254 | 10,079 | 50 | 50 |
| TOTAL | $11,069 | $10,927 | $10,784 | $788 | $821 |
| Total Assets | $12,210 | $12,277 | $12,531 | $3,241 | $2,008 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,671 | 1,191 | 1,406 | 1,175 | 851 |
| Other current liabilities | 1,533 | 23,314 | 21,119 | 8,903 | 7,958 |
| TOTAL | $3,204 | $24,505 | $22,525 | $10,078 | $8,809 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 36,651 | 10,068 | 10,011 | 10,536 | 8,349 |
| TOTAL | $36,651 | $10,068 | $10,011 | $10,478 | $8,348 |
| Total Liabilities | $39,855 | $34,573 | $32,536 | $20,556 | $17,157 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,078 | 1,078 | 1,078 | 1,078 | 1,078 |
| Common Shares | 4 | 4 | 4 | N/A | 4 |
| Retained earnings | -127,557 | -122,156 | -119,487 | -116,210 | -113,507 |
| Other shareholders' equity | -109 | -121 | -111 | -103 | -45 |
| TOTAL | $-27,645 | $-22,296 | $-20,005 | $-17,315 | $-15,149 |
| Total Liabilities And Equity | $12,210 | $12,277 | $12,531 | $3,241 | $2,008 |